Myomo Appoints Joseph M. Manko to Board of Directors
Myomo, Inc. has announced the appointment of Joseph M. Manko Jr. to its Board of Directors, effective May 9, 2026. Mr. Manko, an experienced investor, will serve until the 2027 annual meeting of stockholders, bringing the total number of directors to seven.
BURLINGTON, Mass.–(BUSINESS WIRE)–Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Joseph M. (“Joe”) Manko Jr. as a director effective May 9, 2026, to serve until the 2027 annual meeting of stockholders. With this appointment, Myomo has seven directors. Mr. Manko is an accomplished investor with over 25